Folic acid-d4 Catalog No.:M26551-C Akt and NF-κB are potential

Akt and NF-κB are potential targets for bladder cancer therapy and ursolic acid may serve as a naturally-occurring candidate drug for the prevention and treatment of bladder cancer

RO9021 inhibits anti-IgM induced phosphorylation of BTK

ClH/c1-25(2)22-33(36(43)47-21-20-46-19-18-45-17-16-38)39-35(42)34(41)32(23-26-10-4-3-5-11-26)40-37(44)48-24-31-29-14-8-6-12-27(29)28-13-7-9-15-30(28)31

consistent with a 5-HT 2A receptor mechanism of action in vivo and antipsychotic-like efficacy

Folic acid-d4 Catalog No.:M26551-C Akt and NF-κB are potentialProduct information CAS Number: 171777 72 3 Molecular Weight: 445. 42 Formula: C19H19N7O6 Chemical Name: (2S) 2 [(4 {[(2 amino 4 oxo 3,4 dihydropteridin 6 yl)methyl]amino}(2,3,5,6 H)phenyl)formamido]pentanedioic acid Smiles: [2H]C1=C(NCC2=CN=C3N=C(N)NC(=O)C3=N2)C([2H])=C([2H])C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)=C1[2H] InChiKey: OVBPIULPVIDEAO ALIZGMTFSA N InChi: InChI=1S C19H19N7O6 c20 19 25 15 14(17(30)26 19)23 11(8 22 15)7 21 10 3 1 9(2 4 10)16(29)24